Short-chain fatty acids: ready for prime time?

Nutrition in Clinical Practice

Volumn 21, Issue 4, 2006, Pages 351-366

  Roy, Claude C ^a,b,c   Kien, C Lawrence ^a,b,c   Bouthillier, Lise ^a,b,c   Levy, Emile ^a,b,c,d  

^a Pediatric GI Unit   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; VOLATILE FATTY ACID;

ANIMAL; CARBOHYDRATE METABOLISM; COLON; DIETARY FIBER; DRUG EFFECT; FERMENTATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRANSIT; HUMAN; INTESTINE ABSORPTION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CARBOHYDRATE METABOLISM; COLON; DIETARY FIBER; FATTY ACIDS, VOLATILE; FERMENTATION; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINAL ABSORPTION; PROBIOTICS;

EID: 33845276869     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426506021004351     Document Type: Review

References (133)

1. Roberfroid MB. Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr. 1998;80:S197-S202.
2. Roberfroid MB. Functional foods: concepts and application to inulin and oligofructose. Br J Nutr. 2002;87(suppl 2):S139-S143.
3. Chen CC, Walker WA. Probiotics and prebiotics: role in clinical disease states. Adv Pediatr. 2005;52:77-113.
4. Bergman EN. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 1990; 70:567-590.
5. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031-1064.
6. Tungland BC, Meyer D. Nondigestible oligo-and polysaccharides (dietary fiber): their physiology and role in human health and food. Comprehens Rev Food Sci Food Safety. 2002;73-92.
7. Cummings JH, Rombeau L, Sakata T. Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge University Press; 2004.
8. Small DM. The effects of glyceride structure on absorption and metabolism. Annu Rev Nutr. 1991;11:413-434.
9. Bugaut M, Bentejac M. Biological effects of short-chain fatty acids in nonruminant mammals. Annu Rev Nutr. 1993;13:217-241.
10. Linder MC. Nutrition and Metabolism of Fats: Nutritional Biochemistry and Metabolism, with Clinical Applications. New York, NY: Elsevier; 1988:33-50.
11. Myher JJ, Kuksis A, Marai L, Sandra P. Identification of the more complex triacylglycerols in bovine milk fat by gas chroma-tography-mass spectrometry using polar capillary columns. JChromatogr. 1988;452:93-118.
12. Kien CL, Kepner J, Grotjohn K, Ault K, McClead RE. Stable isotope model for estimating colonic acetate production in premature infants. Gastroenterology. 1992;102:1458-1466.
13. Kien CL, Chang JC, Cooper JR. Butyric acid is synthesized by piglets. J Nutr. 2000;130:234-237.
14. Kien CL, Schmitz-Brown M, Solley T, Sun D, Frankel WL. Increased colonic luminal synthesis of butyric acid is associated with lowered colonic cell proliferation in piglets. J Nutr. 2006; 136:64-69.
15. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115-1118.
16. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.
17. Stephen AM, Cummings JH. The microbial contribution to human faecal mass. J Med Microbiol. 1980;13:45-56.
18. Kien CL, Liechty EA, Mullett MD. Contribution of low-molecular-weight compounds to the fecal excretion of carbohydrate energy in premature infants. Gastroenterology. 1990;99:165-174.
19. Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2005;290:G1089-G1095.
20. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. JPediatr Gastroenterol Nutr. 2000;30:61-67.
21. Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immunol. 2004;5:569-573.
22. Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol. 2004;70:6113-6122.
23. Rao SS, Edwards CA, Austen CJ, Bruce C, Read NW. Impaired colonic fermentation of carbohydrate after ampicillin. Gastroenterology. 1988;94:928-932.
24. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol. 2004;42:1203-1206.
25. Bartlett JG. Clinical practice: antibiotic-associated diarrhea. NEngl J Med. 2002;346:334-339.
26. Barcenilla A, Pryde SE, Martin JC, et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000;66:1654-1661.
27. DeVries JW. On defining dietary fibre. Proc Nutr Soc. 2003;62: 37-43.
28. Jenkins DJ, Kendall CW, Vuksan V. Inulin, oligofructose and intestinal function. J Nutr. 1999;129(7 suppl):1431S-1433S.
29. Barry JL, Hoebler C, Macfarlane GT, et al. Estimation of the fermentability of dietary fibre in vitro: a European interlabora-tory study. Br J Nutr. 1995;74:303-322.
30. Roberfroid MB. Introducing inulin-type fructans. Br J Nutr. 2005;93(suppl 1):S13-S25.
31. Charney AN, Micic L, Egnor RW. Nonionic diffusion of short-chain fatty acids across rat colon. Am J Physiol. 1998;274:G518-G524.
32. Musch MW, Bookstein C, Xie Y, Sellin JH, Chang EB. SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells. Am J Physiol Gastrointest Liver Physiol. 2001;280:G687-G693.
33. Resta-Lenert S, Truong F, Barrett KE, Eckmann L. Inhibition of epithelial chloride secretion by butyrate: role of reduced adenylyl cyclase expression and activity. Am J Physiol Cell Physiol. 2001;281:C1837-C1849.
34. Vidyasagar S, Barmeyer C, Geibel J, Binder HJ, Rajendran VM. Role of short-chain fatty acids in colonic HCO(3) secretion. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1217-G1226.
35. Cuff MA, Lambert DW, Shirazi-Beechey SP. Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J Physiol. 2002;539:361-371.
36. Van Loo JA. Prebiotics promote good health: the basis, the potential, and the emerging evidence. J Clin Gastroenterol. 2004;38(6 Suppl):S70-S75.
37. Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut. 1998;43:478-483.
38. Roediger WEW. The place of short-chain fatty acids in colonocyte metabolism in health and ulcerative colitis: the impaired colonocyte barrier. In: Cummings JH, Rombeau JL, Sakata T, eds. Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge, UK: Cambridge University Press; 1995:337.
39. Lupton JR, Coder DM, Jacobs LR. Influence of luminal pH on rat large bowel epithelial cell cycle. Am J Physiol. 1985;249:G382-G388.
40. Argenzio RA, Meuten DJ. Short-chain fatty acids induce reversible injury of porcine colon. Dig Dis Sci. 1991;36:1459-1468.
41. Lin J, Peng L, Itzkowitz S, Holzman IR, Babyatsky MW. Short-chain fatty acid induces intestinal mucosal injury in newborn rats and down-regulates intestinal trefoil factor gene expression in vivo and in vitro. J Pediatr Gastroenterol Nutr. 2005;41:607-611.
42. Kien CL. Digestion, absorption, and fermentation of carbohydrates in the newborn. Clin Perinatol. 1996;23:211-228.
43. Puchowicz MA, Bederman IR, Comte B, et al. Zonation of acetate labeling across the liver: implications for studies of lipogenesis by MIDA. Am J Physiol. 1999;277:E1022-E1027.
44. Bartholome AL, Albin DM, Baker DH, Hoist JJ, Tappenden KA. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr. 2004;28:210-222.
45. Pool-Zobel BL. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr. 2005;93(suppl 1):S73-S90.
46. Sanderson IR. Short chain fatty acid regulation of signaling genes expressed by the intestinal epithelium. J Nutr. 2004;134: 2450S-2454S.
47. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133(7 suppl):2485S-2493S.
48. White NR, Mulligan P, King PJ, Sanderson IR. Sodium butyrate-mediated Sp3 acetylation represses human insulin-like growth factor binding protein-3 expression in intestinal epithelial cells. J Pediatr Gastroenterol Nutr. 2006;42:134-141.
49. Forchielli ML, Walker WA. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr. 2005;93(suppl 1):S41-S48.
50. Arvans DL, Vavricka SR, Ren H, et al. Luminal bacterial flora determines physiological expression of intestinal epithelial cyto-protective heat shock proteins 25 and 72. Am J Physiol Gastrointest Liver Physiol. 2005;288:G696-G704.
51. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(l) and E(2) production by intestinal myofibroblasts. Gut. 2003;52:1442-1447.
52. Heessen B, Blaut M. Modulation of gut mucosal biofilms. Br J Nutr. 2005;93(suppl 1):S35-S40.
53. Gibson GR, McCartney AL, Rastall RA. Prebiotics and resistance to gastrointestinal infections. Br J Nutr. 2005;93(suppl 1):S31-S34.
54. Manning TS, Gibson GR. Microbial-gut interactions in health and disease: prebiotics. Best Pract Res Clin Gastroenterol. 2004; 18:287-298.
55. Bouhnik Y, Raskine L, Simoneau G, et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr. 2004;80:1658-1664.
56. Guarner F. Inulin and oligofructose: impact on intestinal diseases and disorders. Br J Nutr. 2005;93(suppl 1):S61-S65.
57. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O. The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol. 2004;38(6 suppl):S80-S83.
58. Boehm G, Jelinek J, Stahl B, et al. Prebiotics in infant formulas. J Clin Gastroenterol. 2004;38(6 suppl):S76-S79. -
59. Kien CL, Heitlinger LA, Li BU, Murray RD. Digestion, absorption, and fermentation of carbohydrates. Semin Perinatal. 1989; 13:78-87.
60. Kien CL, McClead RE, Cordero L Jr. Effects of lactose intake on lactose digestion and colonic fermentation in preterm infants. J Pediatr. 1998;133:401-405.
61. Veereman-Wauters G. Application of prebiotics in infant foods. Br J Nutr. 2005;93(suppl 1):S57-S60.
62. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr. 2005;41:186-190. .
63. Euler AR, Mitchell DK, Kline R, Pickering LK. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. J Pediatr Gastroenterol Nutr. 2005;40:157-164.
64. Magne F, Suau A, Pochart P, Desjeux JF. Fecal microbial community in preterm infants. J Pediatr Gastroenterol Nutr. 2005;41:386-392.
65. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 1999;80:F167-F173.
66. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115:1-4.
67. Catala I, Butel MJ, Bensaada M, et al. Oligofructose contributes to the protective role of bifidobacteria in experimental necrotis-ing enterocolitis in quails. J Med Microbiol. 1999;48:89-94.
68. Favre A, Szylit O, Popot F, et al. Diet, length of gestation, and fecal short chain fatty acids in healthy premature neonates. JPEN J Parenter Enteral Nutr. 2002;26:51-56.
69. Rioux KP, Madsen KL, Fedorak RN. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics. Gastroenterol Clin North Am. 2005;34:465-482, ix.
70. Rabbani GH, Albert MJ, Rahman H, Chowdhury AK. Short-chain fatty acids inhibit fluid and electrolyte loss induced by cholera toxin in proximal colon of rabbit in vivo. Dig Dis Sci. 1999;44:1547-1553.
71. Ramakrishna BS, Venkataraman S, Srinivasan P, Dash P, Young GP, Binder HJ. Amylase-resistant starch plus oral rehydration solution for cholera. N Engl J Med. 2000;342:308-313.
72. Macleod RJ, Bennett HP, Hamilton JR. Inhibition of intestinal secretion by rice. Lancet. 1995;346:90-92.
73. Mathews CJ, Macleod RJ, Zheng SX, Hanrahan JW, Bennett HP, Hamilton JR. Characterization of the inhibitory effect of boiled rice on intestinal chloride secretion in guinea pig crypt cells. Gastroenterology. 1999;116:1342-1347.
74. Roller M, Rechkemmer G, VVatzl B. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr. 2004;134:153-156.
75. Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kolodziej B, Naruszewicz M. Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha. J Nutr Biochem. 2004;15:220-228.
76. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002;109:678-684.
77. Holtug K, Clausen MR, Hove H, Christiansen J, Mortensen PB. The colon in carbohydrate malabsorption: short-chain fatty acids, pH, and osmotic diarrhoea. Scand J Gastroenterol. 1992; 27:545-552.
78. Kien CL, Chang JC, Cooper JR, Frankel WL. Effects of prefeeding a prebiotic on diarrhea and colonic cell proliferation in piglets fed lactulose. JPEN J Parenter Enteral Nutr. 2004;28:22-26.
79. Bliss DZ, Guenter PA, Settle RG. Defining and reporting diarrhea in tube-fed patients: what a mess! Am J Clin Nutr. 1992;55:753-759.
80. Thakkar K, Kien CL, Rosenblatt JI, Herndon DN. Diarrhea in severely burned children. JPEN J Parenter Enteral Nutr. 2005; "29:8-11.
81. Schneider SM, Girard-Pipau F, Filippi J, et al. Effects of Sac-charomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol. 2005;11:6165-6169.
82. Schneider SM, Le GP, Girard-Pipau F, et al. Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr. 2000;39:248-255.
83. Lionetti P, Callegari ML, Ferrari S, et al. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr. 2005;29(4 suppl):S173-S175.
84. Bowling TE, Raimundo AH, Grimble GK, Silk DB. Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet. 1993;342:1266-1268.
85. Whelan K, Judd PA, Preedy VR, Simmering R, Jann A, Taylor MA. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr. 2005;135:1896-1902.
86. Zimmaro DM, Rolandelli RH, Koruda MJ, Settle RG, Stein TP, Rombeau JL. Isotonic tube feeding formula induces liquid stool in normal subjects: reversal by pectin. JPEN J Parenter Enteral Nutr. 1989;13:117-123.
87. Whelan K, Judd PA, Preedy VR, Taylor MA. Enteral feeding: the effect on faecal output, the faecal microflora and SCFA concentrations. Proc Nutr Soc. 2004;63:105-113.
88. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911-920.
89. Rook GA, Brunet LR. Give us this day our daily germs. Biologist (Lond). 2002;49:145-149.
90. Borruel N, Casellas F, Antolin M, et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol. 2003;98:865-870.
91. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620-1633.
92. Welters CF, Heineman E, Thunnissen FB, van den Bogaard AE, Soeters PB, Baeten CG. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum. 2002;45:621-627.
93. Hoentjen F, Welling GW, Harmsen HJ, et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11:977-985.
94. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989;320:23-28.
95. Ordein JJ, Di LC, Flores A, Hyman PE. Diversion colitis in children with severe gastrointestinal motility disorders. Am J Gastroenterol. 1992;87:88-90.
96. Roediger WE. Famine, fiber, fatty acids, and failed colonic absorption: does fiber fermentation ameliorate diarrhea? JPEN J Parenter Enteral Nutr. 1994;18:4-8.
97. Roy CC, Bouthillier L, Seidman E, Levy E. New lipids in enteral feeding. Curr Opin Clin Nutr Metab Care. 2004;7:117-122.
98. Nordgaard I, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small-bowel failure proceeds. Am J Clin Nutr. 1996;64:222-231.
99. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet. 1994;343:373-376.
100. Stanley S, Wynne K, Bloom S. Gastrointestinal satiety signals III: glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol. 2004;286:G693-G697.
101. Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr. 2005;93(suppl 1):S157-S161.
102. Tappenden KA, Albin DM, Bartholome AL, Mangian HF. Glu-cagon-like peptide-2 and short-chain fatty acids: a new twist to an old story. J Nutr. 2003;133:3717-3720.
103. Tappenden KA, Drozdowski LA, Thomson AB, McBurney MI. Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr. 1998;68:118-125.
104. Drozdowski LA, Dixon WT, McBurney MI, Thomson AB. Short-chain fatty acids and total parenteral nutrition affect intestinal gene expression. JPEN J Parenter Enteral Nutr. 2002;26:145-150.
105. Mortensen FV, Nielsen H. In vivo and in vitro effects of short-chain fatty acids on intestinal blood circulation. In: Cummings JH, Rombeau JL, Sakata T, eds. Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge: Cambridge University Press; 1995:391.
106. Stephens J, Stoll B, Cottrell J, Chang X, Helmrath M, Burrin DG. Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets. Am J Physiol Regul Integr Comp Physiol. 2006;290:R283-R289.
107. Ropert A, Cherbut C, Roze C, et al. Colonic fermentation and proximal gastric tone in humans. Gastroenterology. 1996;111: 289-296.
108. Piche T, des Varannes SB, Sacher-Huvelin S, Hoist JJ, Cuber JC, Galmiche JP. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology. 2003;124:894-902.
109. Kaur N, Gupta AK. Applications of inulin and oligofructose in health and nutrition. J Biosci. 2002;27:703-714.
110. Hond ED, Geypens B, Ghoos Y. Effect of high performance chicory inulin on constipation. Nutr Res. 2000;20:731-736.
111. Kullen MJ, Bettler J. The delivery of probiotics and prebiotics to infants. Curr Pharm Des. 2005;75:55-74.
112. Treem WR, Ahsan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr. 1996;23:280-286.
113. Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr. 2000;72:1570-1575.
114. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
115. Ferguson LR. Natural and man-made mutagens and carcinogens in the human diet. Mutat Res. 1999;443:1-10.
116. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-696.
117. Park Y, Hunter DJ, Spiegelman D, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA. 2005;294:2849-2857.
118. Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361:1496-1501.
119. Kobayashi H, Tan EM, Fleming SE. Sodium butyrate inhibits cell growth and stimulates p21WAFl/CIPl protein in human colonic adenocarcinoma cells independently of p53 status. Nutr Cancer. 2003;46:202-211.
120. Femia AP, Luceri C, Dolara P, et al. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis. 2002;23:1953-1960.
121. Beyer-Sehlmeyer G, Glei M, Hartmann E, et al. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Br J Nutr. 2003;90:1057-1070.
122. Van LJ, Clune Y, Bennett M, Collins JK. The SYNCAN project: goals, set-up, first results and settings of the human intervention study. Br J Nutr. 2005;93(suppl 1):S91-S98.
123. Beylot M. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr. 2005;93(suppl 1):S163-S168.
124. Hong YH, Nishimura Y, Hishikawa D, et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology. 2005;146:5092-5099.
125. Xiong Y, Miyamoto N, Shibata K, et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci USA 2004;101: 1045-1050.
126. Drzikova B, Dongowski G, Gebhardt E. Dietary fibre-rich oat-based products affect serum lipids, microbiota, formation of short-chain fatty acids and steroids in rats. Br J Nutr. 2005;94: 1012-1025.
127. Marcil V, Delvin E, Seidman E, et al. Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate. Am J Physiol Gastrointest Liver Physiol. 2002;283: G340-G346.
128. Marcil V, Delvin E, Garofalo C, Levy E. Butyrate impairs lipid transport by inhibiting microsomal triglyceride transfer protein in Caco-2 cells. J Nutr. 2003;133:2180-2183.
129. Coudray C, Tressol JC, Gueux E, Rayssiguier Y. Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats. Eur J Nutr. 2003;42:91-98.
130. Griffin IJ, Hicks PMD, Heaney RP, Abrams SA. Enriched chicory inulin increases calcium absorption in girls with lower calcium absorption. Nutr Res. 2003;23:901-909.
131. Tahiri M, Tressol JC, Arnaud J, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study. Am J Clin Nutr. 2003;77:449-457.
132. Kien CL, Murray RD, Ailabouni A, et al. Stable isotope model for assessing production of short chain fatty acids from colon-derived sugar: application in pigs. J Nutr. 1996;126:3069-3076.
133. Tuchy KM, Ronzand GCM. Modulation of the human gut microflora. Curr Pharm Des. 2005;75:75-90.